GLP 1 Drugs and Cancer: A Promising yet Prudent Development Research on GLP 1 drugs has yielded an intriguing finding: patients taking these medications may experience better cancer outcomes, particularly in obesity related cancers such as lung, breast, and colorectal cancer.
This is encouraging news for those fighting the spread of these diseases, but it's essential to approach this development with a critical eye.
Initially designed to treat type 2 diabetes, GLP 1 drugs have gained popularity for weight loss, with one in eight American adults now taking them.